DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Lamond NW. et al.
Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer.

Breast cancer research and treatment 2012;
133: 1115-1123

Download Bibliographical Data

Access:
Access: